Cytosorbents Corporation (CTSO)

Despegar.com Revenue

Cytosorbents had revenue of $8.73M in the quarter ending March 31, 2025, a decrease of -2.92%. This brings the company's revenue in the last twelve months to $35.33M, up 15.37% year-over-year. In the year 2024, Cytosorbents had annual revenue of $35.59M with 14.51% growth.

• Revenue (ttm): $35.33M
• Revenue Growth: +15.37%
• P/S Ratio: 1.46
• Revenue / Employee: $237,129
• Employees: 149
• Market Cap: 53.22M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	35.59M	4.51M	14.51%
Dec 31, 2023	31.08M	-3.60M	-10.39%
Dec 31, 2022	34.69M	-8.48M	-19.64%
Dec 31, 2021	43.17M	2.16M	5.27%
Dec 31, 2020	41.00M	16.06M	64.35%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.